DEFINITIVE PROXY

Company

Phio Pharmaceuticals Corp.

Filed

November 22, 2019

Period of Report

December 12, 2019

Accession Number

0001683168-19-003804

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →